Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer
From MaRDI portal
Publication:123440
DOI10.1038/S41379-020-0544-XWikidataQ91999916 ScholiaQ91999916MaRDI QIDQ123440
Lajos Pusztai, Fahad Ahmed, Veerle Bossuyt, Krisztina Hanley, Emily S Reisenbichler, Kamaljeet Singh, Omar Hameed, Mirna Podoll, Andrew M Bellizzi, Jane Brock, M. Gabriela Kuba, Kimberly Cole, Hannah Wen, Anja C. Roden, David L Rimm, Mary Ann Sanders, Vasiliki Pelekanou, Vesal Yaghoobi, Amy Ly, Dylan Miller, Gang Han, Beth T Harrison, Shi Wei, Oluwole Fadare
Publication date: September 2020
Published in: Modern Pathology (Search for Journal in Brave)
Related Items (1)
This page was built for publication: Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer